Pierre Amarenco

Q: What Schools Are Affiliated With Pierre Amarenco

Pierre Amarenco is affiliated with the following schools: Capital Medical University, Imperial College London, Université Paris Cité, University of Minnesota, McMaster University, Sorbonne Paris North University, Stanford University, Sapienza University of Rome, Paris Diderot University, Duke University, Sorbonne University

Pierre Amarenco's AcademicInfluence.com Rankings

Pierre Amarenco

Medical

#1615

World Rank

#1973

Historical Rank

Neurology

#141

World Rank

#207

Historical Rank

medical Degrees

Pierre Amarenco

Philosophy

#4924

World Rank

#7604

Historical Rank

Logic

#2286

World Rank

#3248

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Pierre Amarenco's Degrees

PhD Neurology Université Paris Cité
Doctorate Medicine Université Paris Cité

Why Is Pierre Amarenco Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Pierre Amarenco's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

High-dose atorvastatin after stroke or transient ischemic attack. (2006) (1547)
Mannheim Carotid Intima-Media Thickness Consensus (2004–2006) (2006) (1475)
Lipoprotein(a) as a cardiovascular risk factor: current status (2010) (1466)
Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004–2006–2011) (2012) (1211)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management (2011) (1099)
Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis (2004) (720)
A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects (2007) (647)
Atrial Septal Aneurysm and Patent Foramen Ovale as Risk Factors for Cryptogenic Stroke in Patients Less Than 55 Years of Age: A Study Using Transesophageal Echocardiography (1993) (581)
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source (2018) (579)
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (2015) (559)
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention (2009) (550)
The prevalence of ulcerated plaques in the aortic arch in patients with stroke. (1992) (547)
Mannheim Intima-Media Thickness Consensus (2004) (531)
Antithrombotic and thrombolytic therapy for ischemic stroke. (1998) (518)
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. (2014) (513)
Cardiovascular Efficacy and Safety of Bococizumab in High‐Risk Patients (2017) (488)
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. (1994) (484)
Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004) (475)
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation (2015) (439)
A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care: A Scientific Statement From the American Heart Association/American Stroke Association (2009) (405)
New England medical center posterior circulation registry (2004) (399)
One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke. (2016) (381)
Classification of Stroke Subtypes (2009) (377)
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial (2014) (369)
Carotid and vertebral artery dissections: three-dimensional time-of-flight MR angiography and MR imaging versus conventional angiography. (1994) (360)
Time course of symptoms in extracranial carotid artery dissections. A series of 80 patients. (1995) (343)
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. (1996) (335)
Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial (2007) (329)
New Approach to Stroke Subtyping: The A-S-C-O (Phenotypic) Classification of Stroke (2009) (296)
Comparison of intravenous alteplase with a combined intravenous–endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study (2009) (289)
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. (2010) (286)
Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. (2009) (283)
The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping) (2013) (273)
Lipid‐Reduction Variability and Antidrug‐Antibody Formation with Bococizumab (2017) (262)
Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. (1997) (258)
Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial (2008) (256)
Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. (2000) (252)
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. (2016) (248)
Common Carotid Artery Intima-Media Thickness and Brain Infarction The Étude du Profil Génétique de l’Infarctus Cérébral (GÉNIC) Case-Control Study (2000) (244)
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study (2018) (244)
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study (2008) (243)
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke. (2019) (230)
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes (2009) (229)
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. (2020) (227)
Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study (2010) (224)
Patent Foramen Ovale Is Stroke Due to Paradoxical Embolism? (1993) (223)
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008) (216)
Carotid Intima-Media Thickness, Plaques, and Framingham Risk Score as Independent Determinants of Stroke Risk (2005) (210)
High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. (2008) (207)
Association Between Influenza Vaccination and Reduced Risk of Brain Infarction (2002) (201)
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial (2011) (197)
Autopsy Prevalence of Intracranial Atherosclerosis in Patients With Fatal Stroke (2008) (194)
Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease (2003) (189)
Cerebellar infarction in the territory of the anterior and inferior cerebellar artery. A clinicopathological study of 20 cases. (1990) (184)
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia (2018) (183)
Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke (2011) (182)
The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. (2000) (181)
Impact of Onset-to-Reperfusion Time on Stroke Mortality: A Collaborative Pooled Analysis (2013) (179)
Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis (2013) (174)
Addition of Brain Infarction to the ABCD2 Score (ABCD2I): A Collaborative Analysis of Unpublished Data on 4574 Patients (2010) (166)
Anterior inferior cerebellar artery territory infarcts. Mechanisms and clinical features. (1993) (165)
The spectrum of cerebellar infarctions (1991) (165)
Embolism from vertebral artery origin occlusive disease (1992) (165)
Ischemia-Modified Albumin in Acute Stroke (2006) (165)
Peduncular 'Rubral' Tremor and Dopaminergic Denervation (1995) (163)
Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis (2011) (160)
Residual macrovascular risk in 2013: what have we learned? (2014) (157)
Diabetes Mellitus, Admission Glucose, and Outcomes After Stroke Thrombolysis: A Registry and Systematic Review (2013) (157)
Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques (2014) (156)
Tremor in Parkinson's disease and serotonergic dysfunction An 11 C-WAY 100635 PET study (2003) (154)
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial (2017) (148)
Prevalence of Coronary Atherosclerosis in Patients With Cerebral Infarction (2011) (147)
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. (2016) (145)
Basilar Artery Atherosclerotic Plaques in Paramedian and Lacunar Pontine Infarctions: A High-Resolution MRI Study (2010) (141)
Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population (2016) (139)
Insular involvement in brain infarction increases risk for cardiac arrhythmia and death (2006) (138)
The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke (2002) (138)
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial (2018) (136)
Cerebellar infarction in the territory of the superior cerebellar artery (1990) (134)
Autopsy Prevalence of Coronary Atherosclerosis in Patients With Fatal Stroke (2007) (134)
Five‐Year Risk of Stroke after TIA or Minor Ischemic Stroke (2018) (133)
Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. (2011) (130)
Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype (2003) (129)
A Policy Statement From the American Heart Association Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care (2013) (128)
Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke (2015) (128)
Infarction in the territory of the medial branch of the posterior inferior cerebellar artery. (1990) (127)
Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. (1993) (127)
Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial (2009) (127)
In vivo middle cerebral artery plaque imaging by high-resolution MRI (2006) (125)
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials (2015) (123)
Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies. (2009) (122)
Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. (2014) (121)
Common carotid artery intima-media thickness and brain infarction : the Etude du Profil Génétique de l'Infarctus Cérébral (GENIC) case-control study. The GENIC Investigators. (2000) (116)
Stent-Assisted Endovascular Thrombolysis Versus Intravenous Thrombolysis in Internal Carotid Artery Dissection With Tandem Internal Carotid and Middle Cerebral Artery Occlusion (2007) (112)
Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke (2004) (110)
Transesophageal Echocardiographic Detection of Aortic Arch Disease in Patients With Cerebral Infarction (1992) (109)
Stroke Research Priorities for the Next Decade – A Representative View of the European Scientific Community (2006) (108)
Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. The GENIC Investigators. (2000) (104)
Costs of Stroke Care according to Handicap Levels and Stroke Subtypes (2003) (104)
Very small (border zone) cerebellar infarcts. Distribution, causes, mechanisms and clinical features. (1993) (103)
Causes and Mechanisms of Territorial and Nonterritorial Cerebellar Infarcts in 115 Consecutive Patients (1994) (103)
Etiology of Stroke (1997) (103)
Long-Term Follow-Up Study of Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis Trial (2014) (101)
Cerebellar infarcts in the New England Medical Center Posterior Circulation Stroke Registry (1994) (100)
Pathophysiology, presentation, prognosis, and management of intracranial arterial dolichoectasia (2015) (100)
Stroke prevention, blood cholesterol, and statins (2004) (99)
Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA (2011) (96)
Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial (2019) (96)
Arterial pathology in cerebellar infarction. (1990) (95)
Intracranial arterial dolichoectasia and small‐vessel disease in stroke patients (2005) (95)
High-resolution MRI identifies basilar artery plaques in paramedian pontine infarct (2005) (93)
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. (2009) (91)
Horizontal eye movement disorders after posterior vermis infarctions. (1995) (89)
Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study (2008) (88)
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial (2016) (88)
Predictors for malignant middle cerebral artery infarctions (2006) (88)
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential (2019) (84)
Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction (2001) (84)
Statins for stroke prevention: disappointment and hope. (2004) (82)
Multiple microembolic borderzone brain infarctions and endomyocardial fibrosis in idiopathic hypereosinophilic syndrome and in Schistosoma mansoni infestation (2004) (82)
Coronary Heart Disease Risk in Patients With Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease: Findings From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial (2010) (80)
Blood–brain barrier disruption is associated with increased mortality after endovascular therapy (2013) (78)
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data (2020) (78)
Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. (2018) (78)
Combination Therapy With Clopidogrel and Aspirin: Can the CURE Results Be Extrapolated to Cerebrovascular Patients? (2001) (74)
Association of Small-Vessel Disease With Dilatative Arteriopathy of the Brain: Neuropathologic Evidence (2007) (73)
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. (2000) (72)
Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis. (2010) (72)
Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial (2009) (71)
Carotid Atherosclerosis and Risk of Subsequent Coronary Event in Outpatients With Atherothrombosis (2013) (70)
A History of Stroke/Transient Ischemic Attack Indicates High Risks of Cardiovascular Event and Hemorrhagic Stroke in Patients With Coronary Artery Disease (2013) (70)
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack (2009) (69)
Does ABCD2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack? (2009) (68)
Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases (2001) (66)
Paravermal infarct and isolated cerebellar dysarthria (1991) (63)
Bridging Therapy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis (2012) (62)
Underlying Pathology of Stroke of Unknown Cause (Cryptogenic Stroke) (2009) (62)
Patients With Transient Ischemic Attack With ABCD2 <4 Can Have Similar 90-Day Stroke Risk as Patients With Transient Ischemic Attack With ABCD2 ≥4 (2012) (62)
Outcomes of Mechanical Endovascular Therapy for Acute Ischemic Stroke: A Clinical Registry Study and Systematic Review (2011) (62)
Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease (2017) (62)
Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis. (2019) (61)
Infarction in the anterior rostral cerebellum (the territory of the lateral branch of the superior cerebellar artery) (1991) (60)
Cytokine Polymorphisms Associated With Carotid Intima-Media Thickness in Stroke Patients (2006) (60)
Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients (2014) (60)
Correlation between the Framingham risk score and intima media thickness: the Paroi Artérielle et Risque Cardio-vasculaire (PARC) study. (2007) (60)
Soluble Thrombomodulin and Brain Infarction: Case–Control and Prospective Study (2004) (55)
Renin–angiotensin–aldosterone system in brain infarction and vascular death (2005) (55)
Vermal infarct with pursuit eye movement disorders. (1990) (55)
A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial (2019) (55)
Ischaemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for body building (2000) (55)
Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial. (2019) (54)
Outcomes of Intravenous Recombinant Tissue Plasminogen Activator Therapy According to Gender: A Clinical Registry Study and Systematic Review (2009) (54)
Yield of systematic transcranial doppler in patients with transient ischemic attack (2009) (51)
Impact of Diffusion-Weighted Imaging Lesion Volume on the Success of Endovascular Reperfusion Therapy (2013) (51)
Pain as the Only Manifestation of Internal Carotid Artery Dissection (1992) (50)
Blood Lipids in Brain Infarction Subtypes (2006) (50)
Protective Effect of High-Density Lipoprotein-Based Therapy in a Model of Embolic Stroke (2010) (49)
Global Prospective Safety Analysis of Rivaroxaban. (2018) (48)
Polymorphism R92Q of the tumour necrosis factor receptor 1 gene is associated with myocardial infarction and carotid intima-media thickness – The ECTIM, AXA, EVA and GENIC Studies (2004) (48)
Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome. (2003) (48)
[Anatomy of the cerebellar arteries]. (1989) (48)
Genetic susceptibility and ischaemic stroke. (1999) (48)
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. (2022) (48)
Socioeconomic Aspects of Postacute Care for Patients with Brain Infarction in France (2002) (47)
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. (2018) (46)
Carotid Artery Dissection With Renal Infarcts: Two Cases (1994) (45)
High blood pressure in early acute stroke: a sign of a poor outcome? (2006) (45)
Matrix metalloproteinase‐3 and intracranial arterial dolichoectasia (2010) (45)
Spectrum of Transient Visual Symptoms in a Transient Ischemic Attack Cohort (2013) (45)
Cyclosporine in acute ischemic stroke (2015) (45)
Coronary Artery Disease and Risk of Major Vascular Events After Cerebral Infarction (2013) (44)
AMOBES (Active Mobility Very Early After Stroke): A Randomized Controlled Trial (2017) (44)
Brain infarction following 5-fluorouracil and cisplatin therapy (1998) (44)
Basilar Artery Diameter and 5-Year Mortality in Patients With Stroke (2006) (44)
Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review. (2007) (43)
Effect of In-Hospital Remote Ischemic Perconditioning on Brain Infarction Growth and Clinical Outcomes in Patients With Acute Ischemic Stroke: The RESCUE BRAIN Randomized Clinical Trial. (2020) (43)
The dynamics of statins: from event prevention to neuroprotection. (2006) (41)
Mitral valve strands and the risk of ischemic stroke in elderly patients. The French Study of Aortic Plaques in Stroke (FAPS) Investigators. (1997) (41)
HDL-C, triglycerides and carotid IMT: a meta-analysis of 21,000 patients with automated edge detection IMT measurement. (2014) (41)
Carotid endarterectomy in the acute phase of stroke-in-evolution is safe and effective in selected patients. (2012) (41)
[Cerebellar infarction in the area of the posterior cerebellar artery. Clinicopathology of 28 cases]. (1989) (41)
The paradox of cholesterol and stroke (2007) (40)
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Etiology of stroke. (1997) (40)
Adverse Associations Between CX3CR1 Polymorphisms and Risk of Cardiovascular or Cerebrovascular Disease (2005) (40)
Overlap of Diseases Underlying Ischemic Stroke: The ASCOD Phenotyping (2013) (40)
Cerebral and Extracerebral Vasoreactivity in Symptomatic Lacunar Stroke Patients: A Case-Control Study (2013) (39)
AHA/ASA Scientific Statement A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care (2009) (38)
Impact of Diffusion-Weighted Imaging Alberta Stroke Program Early Computed Tomography Score on the Success of Endovascular Reperfusion Therapy (2014) (38)
Autopsy Prevalence of Proximal Extracranial Atherosclerosis in Patients With Fatal Stroke (2009) (38)
Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. (2009) (38)
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis? (2016) (38)
High-density Lipoprotein–based Therapy Reduces the Hemorrhagic Complications Associated With Tissue Plasminogen Activator Treatment in Experimental Stroke (2013) (37)
High-Density Lipoproteins Limit Neutrophil-Induced Damage to the Blood–Brain Barrier in Vitro (2013) (37)
Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study (2001) (37)
Cerebral Infarction Due to Painless Thoracic Aortic and Common Carotid Artery Dissections (1993) (37)
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin (2020) (35)
Characterization of Polymorphic Structure of Cathepsin G Gene: Role in Cardiovascular and Cerebrovascular Diseases (2001) (35)
Reversible leukoencephalopathy in cerebral amyloid angiopathy presenting as subacute dementia (2002) (35)
Roller-coaster-induced vertebral artery dissection (1995) (35)
Dramatic Recovery in Acute Ischemic Stroke Is Associated With Arterial Recanalization Grade and Speed (2012) (35)
Does ABCD 2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack ? (2009) (34)
The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study: Baseline Characteristics of the Population (2009) (34)
Stroke prevention, blood cholesterol and statins. (2005) (33)
Cerebellar hemorrhagic infarction (1996) (33)
Cryptogenic Stroke, Aortic Arch Atheroma, Patent Foramen Ovale, and the Risk of Stroke (2005) (32)
Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry (2019) (32)
Patent foramen ovale and the risk of stroke: smoking gun guilty by association? (2005) (32)
A multicenter, randomized trial on neuroprotection with remote ischemic per-conditioning during acute ischemic stroke: the REmote iSchemic Conditioning in acUtE BRAin INfarction study protocol (2016) (32)
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (2014) (32)
Quality of life after decompressive craniectomy for malignant middle cerebral artery infarction (2005) (32)
Dysfunctional HDL in acute stroke. (2016) (32)
Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial (2017) (32)
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe (2019) (32)
Diffusion weighted imaging of cerebellar lesions in Wernicke's encephalopathy. (2006) (32)
Effect of High-Dose Atorvastatin on Renal Function in Subjects With Stroke or Transient Ischemic Attack in the SPARCL Trial (2014) (31)
Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy (2016) (31)
The renin-angiotensin-aldosterone system in cerebral small vessel disease (2008) (31)
Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets (2017) (30)
Country-Based Reference Values and Impact of Cardiovascular Risk Factors on Carotid Intima-Media Thickness in a French Population: The ‘Paroi Artérielle et Risque Cardio-Vasculaire’ (PARC) Study (2009) (29)
Cost of a recurrent vs. cost of first‐ever stroke over an 18‐month period (2003) (29)
Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes) (2017) (29)
Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta (2004) (29)
Lessons from carotid endarterectomy and stenting trials (2010) (29)
Safety and Dose-Escalation Study Design of Transcranial Ultrasound in Clinical Sonolysis for Acute Ischemic Stroke: The TUCSON Trial (2009) (29)
Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke (2014) (29)
Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (Socrates) Trial: Rationale and Design (2015) (28)
Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry (2014) (28)
Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL). (2014) (28)
Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference (2013) (28)
Is Moderate Atherosclerotic Stenosis in the Middle Cerebral Artery a Cause of or a Coincidental Finding in Ischemic Stroke? (2009) (28)
Outcomes after thrombolysis in AIS according to prior statin use (2012) (27)
Disability after minor stroke and TIA (2019) (26)
Concurrent dolichoectasia of basilar and coronary arteries (2005) (26)
Telemedicine for Improving Emergent Management of Acute Cerebrovascular Syndromes (2007) (26)
Should the MATCH Results Be Extrapolated to All Stroke Patients and Affect Ongoing Trials Evaluating Clopidogrel Plus Aspirin? (2004) (26)
Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure. (2014) (26)
Atherothrombosis and the role of antiplatelet therapy (2011) (26)
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes) (2017) (25)
The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design (2019) (25)
Progressive supranuclear palsy as the sole manifestation of systemic Whipple's disease treated with pefloxacine. (1991) (25)
Stent assisted endovascular thrombolysis of internal carotid artery dissection (2005) (25)
Atherogenic Dyslipidemia in Patients With Transient Ischemic Attack (2011) (24)
[Hyperglycemia: a predictor of poor prognosis in acute stroke]. (2001) (24)
Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke prevention. (2008) (24)
Predictive Values of Lacunar Transient Ischemic Attacks (2004) (24)
Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study (2019) (23)
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022) (23)
Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke (2020) (23)
Cardiac causes of stroke (2000) (23)
Aortic arch atheroma in transient ischemic attack patients. (2013) (23)
Tako-Tsubo Syndrome: A Cardioembolic Cause of Brain Infarction (2010) (22)
An update on aortic causes of ischemic stroke (1997) (22)
Impact of a Combined Intravenous/ Intra-Arterial Approach in Octogenarians (2011) (22)
Effect of statins in stroke prevention (2005) (22)
Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack (2019) (21)
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories in the SPARCL Trial. (2020) (21)
Carotid endarterectomy in the acute phase of crescendo cerebral transient ischemic attacks is safe and effective. (2011) (21)
Demographics, Socio-Economic Characteristics, and Risk Factor Prevalence in Patients with Non-Cardioembolic Ischaemic Stroke in Low- and Middle-Income Countries: The OPTIC Registry (2013) (20)
Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial (2018) (20)
Statins for Secondary Stroke Prevention in Patients without Known Coronary Heart Disease: The Jury Is Still Out (2004) (19)
Clinical Significance of Isolated Atypical Transient Symptoms in a Cohort With Transient Ischemic Attack (2017) (19)
Influence of visual information on cerebellar saccadic dysmetria (1994) (19)
Aortic arch atheroma and the risk of stroke (2006) (19)
Plasminogen activator inhibitor genotype and brain infarction. (2001) (19)
Transient Ischemic Attack. (2020) (19)
Rupture of nonstenotic carotid plaque as a cause of ischemic stroke evidenced by multimodality imaging. (2014) (19)
Efficacy of Endovascular Therapy in Acute Ischemic Stroke Depends on Age and Clinical Severity (2018) (19)
Prehospital stroke care: potential, pitfalls, and future (2010) (18)
Coronary and Basilar Artery Ectasia Are Associated: Results From an Autopsy Case–Control Study (2016) (18)
Amyloid Angiopathy in Brain Hemorrhage: A Postmortem Neuropathological-Magnetic Resonance Imaging Study (2018) (18)
The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment (2017) (18)
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source (2017) (18)
Outcomes after Stroke Thrombolysis According to Prior Antiplatelet Use (2015) (17)
Glucose Level and Brain Infarction: A Prospective Case-Control Study and Prospective Study (2009) (17)
Prevalence and Determinants of Subdiaphragmatic Visceral Infarction in Patients With Fatal Stroke (2007) (17)
Post-stroke changes in cortical 5-HT2 serotonergic receptors. (1996) (17)
Frequency of migraine attacks following stroke starts to decrease before PFO closure (2006) (16)
Impact of Initial Diffusion-Weighted Imaging Lesion Growth Rate on the Success of Endovascular Reperfusion Therapy (2016) (16)
TRUST-tPA trial: Telemedicine for remote collaboration with urgentists for stroke-tPA treatment (2017) (16)
TIA clinic: a major advance in management of transient ischemic attacks. (2014) (16)
Primary somatosensory cortex activation is not altered in patients with ventroposterior thalamic lesions: a PET study. (1999) (15)
Atherosclerosis of the thoracic aorta: from risk stratification to treatment. (2002) (15)
The Smoking Paradox: Impact of Smoking on Recanalization in the Setting of Intra-Arterial Thrombolysis (2014) (15)
High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects (2020) (15)
32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT (2011) (15)
Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study (2018) (15)
Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban (2020) (15)
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke (2020) (14)
Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokes (2019) (14)
Differences in Characteristics and Outcomes Between Asian and Non-Asian Patients in the TIAregistry.org (2017) (14)
Reperfusion therapy in acute cerebrovascular syndrome. (2011) (14)
Statins and Stroke Prevention (2003) (14)
Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin (2020) (14)
“Telethrombolysis”: stroke consultation by telemedicine (2008) (13)
Aortic source of brain embolism (2003) (13)
[Cerebellar infarctions and their mechanisms]. (1993) (13)
Polypill Strategy vs. Prevention Clinics for Stroke Prevention (2006) (13)
Chlamydia pneumoniae seropositivity in aetiological subtypes of brain infarction and carotid atherosclerosis: a case–control study (2007) (13)
Athérosclérose de la crosse de l'aorte et risque d'infarctus cérébral (2001) (12)
Impact of Low Ankle-Brachial Index on the Risk of Recurrent Vascular Events: Insights From the OPTIC Registry (2019) (12)
Accidents ischémiques cérébraux et chimiothérapie anti-cancéreuse (2003) (12)
Stroke syndromes: Cerebellar stroke syndromes (2001) (12)
Prevalence of subdiaphragmatic visceral infarction in cardioembolic stroke (2010) (12)
Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy. (2020) (12)
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial). (2008) (12)
Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke (2016) (12)
Low Levels of Low-Density Lipoprotein-C Associated With Proprotein Convertase Subtilisin Kexin 9 Inhibition Do Not Increase the Risk of Hemorrhagic Transformation (2014) (12)
Headache in 67 Patients with Extra Cranial Internal Carotid Artery Dissection (1991) (11)
Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study (2018) (11)
Aortic Sources of Embolism (2021) (11)
Lipid lowering and recurrent stroke: another stroke paradox? (2005) (11)
Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial (2020) (11)
Impact of Living and Socioeconomic Characteristics on Cardiovascular Risk in Ischemic Stroke Patients (2014) (11)
Infarctus pontin inférolatéral: deux aspects cliniques. (1990) (11)
Thrombomodulin gene polymorphisms in brain infarction and mortality after stroke (2008) (10)
New prospects for PCSK9 inhibition? (2018) (10)
close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design (2016) (10)
Flow-mediated vasodilatation of carotid and brachial arteries in healthy subjects and in lacunar stroke patients. (2006) (10)
Risk of Stroke after Transient Ischemic Attack or Minor Stroke. (2016) (10)
Effect of mitoxantrone on MRI in progressive MS : Results of the MIMS trial. Author's reply (2006) (10)
Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting (2017) (10)
Osteopontin gene variation and cardio/cerebrovascular disease phenotypes. (2010) (9)
Stroke and Vascular Mortality Trends in France: 1979–2001 (2007) (9)
Atorvastatin in prevention of stroke and transient ischaemic attack (2007) (9)
Not all patients should be admitted to the hospital for observation after a transient ischemic attack. (2012) (9)
[Recommendations for the use of intravenous thrombolytic therapy in cerebrovascular ischemic accident. French Society of Neurovascular Disorders]. (2000) (9)
Statin therapy and stroke prevention: what was known, what is new and what is next? (2007) (9)
Is Intracerebral Hemorrhage a Time-Dependent Phenomenon After Successful Combined Intravenous and Intra-Arterial Therapy? (2013) (8)
Five-Year Prognosis After TIA or Minor Ischemic Stroke in Asian and Non-Asian Populations (2020) (8)
Changes in High-Density Lipoproteins Related to Outcomes in Patients with Acute Stroke (2020) (8)
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS (2017) (8)
TIA as Acute Cerebrovascular Syndrome (2013) (8)
Prevention and health services delivery. (2003) (8)
Japanese Versus Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: Subanalysis of TIA registry.org. (2019) (8)
Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. (2017) (8)
[Münchhausen syndrome. A study of 8 cases of neurologic manifestations]. (1991) (8)
Abstract 2985: Lipoprotein, Blood Pressure and Stroke Risk: Findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study (2006) (7)
EXPRESS transient ischemic attack study: speed the process! (2008) (7)
Prevalence of nephroangiosclerosis in patients with fatal stroke (2009) (7)
Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. (2014) (7)
Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial (2019) (7)
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention. (2022) (7)
Residual Microvascular Risk in Type 2 Diabetes in 2014: Is it Time for a Re-Think? A Perspective from the Residual Risk Reduction Initiative (R3i) (2014) (7)
Endocardite aortique et mitrale à Haemophilus paraphrophilus avec abcès de l'anneau aortique et embolies cérébrales. (1989) (7)
Aspects socio-économiques de la prise en charge de l’attaque cérébrale (2004) (7)
[Edematous cerebellar infarction. A clinico-pathological study of 16 cases]. (1990) (7)
and Pierre Oxide Synthase Gene and Brain Infarction Association Between the Glu 298 Asp Polymorphism in the Endothelial Constitutive Nitric (2000) (7)
Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke (2021) (6)
Oral microbiota and atherothrombotic carotid plaque vulnerability in periodontitis patients. A cross-sectional study. (2020) (6)
[Evaluation of aortic atherosclerosis by transesophageal echocardiography. Prognostic implications]. (1997) (6)
[Socio-economic aspects of stroke management]. (2004) (6)
Protective Effect of ApoA1 (Apolipoprotein A1)-Milano in a Rat Model of Large Vessel Occlusion Stroke (2020) (6)
[Atherosclerotic aortic plaques and risk of embolic stroke]. (2001) (6)
Update on imaging aortic atherosclerosis. (2003) (6)
Blood cholesterol and vascular mortality by age, sex, and blood pressure : a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Commentary (2007) (6)
[Subthalamic tuberculoma disclosed by hemiballism. Efficacy of antituberculous treatment]. (1983) (6)
[Cerebral ischemic events and anti-cancer therapy]. (2003) (6)
Prevalence of Embolic Signals in Acute Coronary Syndromes (2010) (6)
Serum and CSF humoral immunity in Guillain-Barré syndrome: Clinical correlations (1987) (6)
[Feasibility of percutaneous exclusion of the left atrial appendage: results of 11 cases]. (2006) (5)
[Spinal dural arteriovenous fistulae: exacerbation after myelography with metrizamide]. (1988) (5)
Vertebral artery dissection presenting as neuralgic amyotrophy (2002) (5)
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial (2020) (5)
[Cerebrovascular stroke: epidemiology, etiology, physiopathology, diagnosis, course, treatment]. (1998) (5)
Lipomatous Hypertrophy of the Inter-Atrial Septum and Stroke (2004) (5)
Mise au point sur les démences vasculaires (2008) (5)
Up-to-Date Meta-Analysis Statins in Stroke Prevention and Carotid Atherosclerosis : Systematic Review and (2004) (5)
Accident ischémique transitoire (2007) (5)
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack (2021) (4)
Une cause méconnue de fièvre prolongée: à propos de six cas de dissection aortique chronique (1998) (4)
The role of statins in the prevention of stroke (2008) (4)
[Vesical neuropathy in systemic vasculitis: 3 cases]. (1988) (4)
[The value of MRI in a case of cerebro-meningeal miliary carcinomatosis of melanotic origin]. (1989) (4)
Percutaneous Patent Foramen Ovale (PFO) closure in young patients with both cryptogenic brain infarction and PFO associated with Atrial Septal Aneurysm (ASA). (2006) (4)
Stroke subtypes and interventional studies for transient ischemic attack. (2014) (4)
Blood Lipids and Stroke: What More Can We Do Besides Reducing Low-Density Lipoprotein Cholesterol? (2011) (4)
Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study (2022) (4)
Bladder neuropathy in periarteritis nodosa. (1989) (4)
Evaluation of non-stenotic carotid atherosclerotic plaques with combined FDG-PET imaging and CT angiography in patients with ischemic stroke of unknown origin (2021) (4)
Blood Pressure and Lipid Lowering in the Prevention of Stroke: A Note to Neurologists (2003) (3)
Statins in stroke prevention (2008) (3)
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack (2022) (3)
Twelve-month outcome in patients with stroke and atrial fibrillation not suitable to oral anticoagulant strategy: the WATCH-AF registry (2019) (3)
[Amnesic syndrome caused by infarction in the area of the left anterior choroidal artery]. (1988) (3)
Abstract 2173: Effect of High-dose Atorvastatin on Changes in Renal Function: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) Trial (2007) (3)
Evaluation de l'athérosclérose aortique par échocardiographie transoesophagienne : Implications pronostiques (1997) (3)
Intracranial Hemorrhage in the TST Trial (2021) (3)
Letter to the Editor: Lambl's Excrescences and Stroke (2000) (3)
P3592Safety analysis of rivaroxaban: a pooled analysis of the global XANTUS programme (real-world, prospective, observational studies for stroke prevention in patients with atrial fibrillation) (2017) (3)
[Cerebellar infarction]. (2020) (3)
Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial (2019) (3)
Neuropathie vésicale au cours de vascularites systémiques: trois observations. (1988) (3)
Monday, 27 August 2012 (2012) (3)
[Update on vascular dementias]. (2008) (3)
Thrombolyse et infarctus cérébral aigu (2004) (3)
[Atherosclerosis of the aortic arch. A source of cerebral embolism?]. (1992) (3)
Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target Trial (2022) (3)
Intraplaque hemorrhage, a potential consequence of periodontal bacteria gathering in human carotid atherothrombosis. (2016) (3)
P916 Pharmacodynamlcs and pharmacoklnetics of the novel anti-platelet agent, clopldogrel, In the young and the elderly with and without symptomatic atherosclerosis (2004) (3)
Molecular investigation of the functional relevance of missense variants of ICAM-1. (2008) (3)
Ipsilateral internal carotid artery redissection on anticoagulation. (1995) (2)
[Ocular myasthenia: an etiology to consider in unexplained oculomotor paralysis]. (1994) (2)
Specificities of Ischemic Stroke Risk Factors in Arab-Speaking Countries (2017) (2)
Cerebral microemboli: smoking gun or innocent bystanders? (2010) (2)
Abstract 2182: Stroke and TIA as CHD Risk Equivalents: Findings From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study (2006) (2)
[Legionella pneumophila pneumonia and septicemia. Fatal complications of hairy cell leukemia developing for 27 years]. (1984) (2)
An International Report on the Adaptations of Rapid Transient Ischaemic Attack Pathways During the COVID-19 Pandemic (2020) (2)
WATERSHED INFARCTION DUE TO ACUTE HYPEREOSINOPHILIA (2008) (2)
Lambl's excrescences and stroke. (2000) (2)
Aspirin's Benefits Were Previously Underestimated and Are Primarily Accrued in the Acute Setting. (2017) (2)
Endogenous tissue‐type plasminogen activator and cardioembolic brain infarct subtype (2006) (2)
Subject Index Vol. 20, Suppl. 2, 2005 (2005) (2)
[Distal infarction of the left superior cerebellar artery presenting with dysarthria and unsteadiness]. (1988) (2)
Subject Index Vol. 17, Suppl. 1, 2004 (2003) (2)
Electrocardiographic changes in acute stroke (2001) (2)
Feasibility and Exploratory Efficacy Evaluation of the Embrella Embolic Deflector System for the Prevention ofCerebral Emboli in Patients Undergoing Transcatheter Aortic ValveReplacement (2)
[Vesico-sphincter disorders in neurosyphilis]. (1989) (2)
Stroke Syndromes: Cerebellar infarcts (2012) (2)
PO23-781 ATORVASTATIN REDUCES RISK OF STROKE, CARDIAC EVENTS AND ENDARTERECTOMY IN PATIENTS WITH CAROTID STENOSIS: A SUBSTUDY OF SPARCL (2007) (2)
A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea (2020) (2)
[External ophthalmoplegia in barbiturate poisoning]. (1984) (2)
Japanese and Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: A Five-Year Risk Analysis of Stroke and Vascular Events (2020) (2)
[Unusual and unknown complication of ascites: meralgia paresthetica]. (1990) (2)
Minor Ischemic Stroke and a Smoldering Case of Giant-Cell Arteritis: A Case Report (2021) (2)
Neurosyphilis tardive: maladie d'actualité (1989) (2)
Une cause rare d'incontinence urinaire curable: l'artérite giganto-cellulaire (1987) (2)
Crosse de l'aorte et risque artériel cérébral (1998) (2)
Neuro-vessie périphérique par zona périnéal (1986) (2)
Abstract TMP20: Efficacy and Safety of Ticagrelor in Relation to Prior Aspirin Usage in the SOCRATES Trial (2017) (1)
[An unknown cause of prolonged fever: apropos of 6 cases of chronic aortic dissection]. (1998) (1)
[Peripheral neurogenic bladder due to perineal zona]. (1986) (1)
Traitement thrombolytique : plaidoyer pour une prise en charge experte hyperurgente de l’occlusion artérielle cérébrale aiguë (1996) (1)
Une complication rare et méconnue de l'ascite : la méralgie paresthésique (1990) (1)
[Aortic and mitral endocarditis caused by Haemophilus paraphrophilus with abscess of the aortic ring and cerebral embolism]. (1989) (1)
Temporary application of lower body positive pressure improves intracranial velocities in symptomatic acute carotid occlusion or tight stenosis: A pilot study (2021) (1)
[Bladder globus in the origin of paresthesic meralgia]. (1987) (1)
Book Review Brain Embolism (Neurological Disease and Therapy. 81.) Edited by Louis R. Caplan and Warren J. Manning. 348 pp., illustrated. New York, Informa Healthcare, 2006. $199.95. 978-0-8247-2929-5 (2007) (1)
Clinical genetic issues in stroke. (2009) (1)
Prise en charge de l'ischémie cérébrale à la phase aiguë (2002) (1)
II. Faut-il fermer un foramen ovale perméable après un premier infarctus cérébral de cause inconnue chez le sujet de moins de 60 ans ? (2006) (1)
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. Reply. (2020) (1)
Un site web et sa revue (2009) (1)
Dolichoectasies artérielles intracrâniennes (2008) (1)
Ischémie cérébrale et anticorps antiphospholipides : coupables par association (1992) (1)
Subject Index Vol. 27, Suppl. 1, 2009 (2009) (1)
Bridging Therapy in Acute Ischemic Stroke (2012) (1)
Prevalence and Outcome of Potential Candidates for Left Atrial Appendage Closure After Stroke With Atrial Fibrillation (2020) (1)
«Double crush syndrome» à l'origine d'un syndrome du nerf interosseux antérieur (1987) (1)
Abstract 14940: Association of MCP-1, hsCRP, Neopterin, MMP-9 and NT-proBNP With Coronary Heart Disease Risk in Patients With Prior Stroke or Transient Ischemic Attack. Results of the Analysis of 13 Biomarkers From the SPARCL Trial (2013) (1)
Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. (2020) (1)
The Archer's Eye (1993) (1)
[Thrombolysis and acute cerebral infarction]. (2004) (1)
[Atherosclerosis of the aortic arch: a possible new source of cerebral embolism]. (1994) (1)
Athérosclérose aortique : marqueur du risque vasculaire (1997) (1)
L'infarctus du cervelet : un modèle pour l'étude des mécanismes de l'ischémie vertébrobasilaire (1992) (1)
Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms (2022) (1)
Learning from TARDIS: time for more focused trials in stroke prevention (2017) (1)
Anomalies électrocardiographiques à la phase aiguë de l'infarctus cérébral (2001) (1)
Transient Ischemic Attack. Reply. (2020) (1)
Tuesday, 28 August 2012 (2012) (1)
Higher Aspirin Dose is Associated with Reduced Mortality and More Serious Bleeding in Patients with Recent Cerebrovascular or Coronary Ischemic Events: Insights from the BRAVO Trial (2003) (1)
P2561Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe (2018) (0)
55th AAN: American Academy of Neurology (2003) (0)
Subject Index Vol. 18, 2004 (2004) (0)
[Late neurosyphilis: a current disease]. (1989) (0)
Vascular origin in acute transient visual disturbance: A prospective study (2021) (0)
Contents Vol. 31, 2011 (2011) (0)
Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study (2023) (0)
How should I treat a symptomatic post dissection carotid aneurysm? (2014) (0)
[Double crush syndrome as the origin of an anterior interosseous nerve syndrome]. (1987) (0)
Results Identification of Polymorphisms in the CTSG Gene and Distribution of Genotypes and Alleles in Patients and Controls in the ECTIM and GENIC Studies (2001) (0)
478 Relationship between atrial septum morphology and the presence of a residual shunt after percutaneous device closure of patent foramen ovale (2006) (0)
Intra-arterial thrombolysis and stroke (2002) (0)
[Transient ischemic attacks]. (2007) (0)
Remote Ischemic Conditioning vs Usual Care and Neurologic Function in Acute Moderate Ischemic Stroke. (2022) (0)
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES) (2023) (0)
The ATHENA study (2010) (0)
Contents Vol. 27, 2009 (2009) (0)
[How I treat and manage a carotid stenosis]. (1996) (0)
Chirurgie carotide : la fin de NASCET. 23rd Joint international conference on stroke and cerebral circulation (Orlando, Floride, 4-7 février 1998) (1998) (0)
Impact of Lower vs Higher LDL Cholesterol Targets on Cardiovascular Events After Ischemic Stroke in Diabetic Patients (0)
Iconography : Diffusion weighted imaging of cerebellar lesions in Wernicke’s encephalopathy (2008) (0)
Tremblement d'attitude et encéphalopathie révélateurs d'un syndrome de Conn (1989) (0)
Patients with TIA and minor ischemic stroke who underwent carotid revascularization remain at higher risk than other patients (2015) (0)
Aortic Arch Atherosclerotic Disease: A New Potential Source of Brain Embolism (1997) (0)
Genetic epidemiological studies of stroke Study Prospective Patients Controls Stroke subtypes Multivariate analysis Genetic / familial factors for stroke (2008) (0)
Therapeutic use of HDL in ischemic stroke (2013) (0)
Infarction intheterritory ofthemedial branch of theposterior inferior cerebellar artery (1990) (0)
Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study (2017) (0)
Actualité en prévention secondaire de l'infarctus cérébral (2001) (0)
[Vesical neuropathy in acute disseminated lupus erythematosus. 2 cases]. (1988) (0)
Subject Index Vol. 27, 2009 (2009) (0)
Background—It is unclear whether levels of high-density lipoprotein cholesterol (HDL-C) or apolipoprotein A-I (apoA-I) remain inversely associated with cardiovascular risk among patients who achieve very low levels of low-density lipoprotein cholesterol on statin therapy. It is also unknown whether (2013) (0)
Aortic Arch Atherosclerotic Disease (2001) (0)
Secondary prevention of stroke today (2001) (0)
Abstract 12462: Improved Treatment Satisfaction Independent of Stroke and Bleeding Risk Among Patients Transitioned From a Vitamin K Antagonist to Rivaroxaban: A XANTUS-ACTS Analysis (2016) (0)
P305Value of aortic TBR measured on FDG-PET for the prediction of atherothrombotic events in a cohort of patients with overt coronary and carotid atherosclerotic disease (2019) (0)
Evaluation of antiplatelet therapy-Event prevention and risk of hemorrhage (2005) (0)
Abstract 13033: Osteopontin and Neopterin Predict Stroke Risk in Patients with Prior Stroke or Transient Ischemic Attack. Results of the Analysis of 13 Biomarkers from the SPARCL Study (2010) (0)
Abstract WP52: Impact of Baseline DWI ASPECTS Lesion Topology on Functional Outcome after Endovascular Treatment (2016) (0)
building bodyMaHuang extract and creatine monohydrate for Ischaemic stroke in a sportsman who consumed (1999) (0)
08-80 - RESIDUAL SHUNT AFTER PERCUTANEOUS CLOSURE IS RELATED TO PATENT FORAMEN OVALE ANATOMY (2008) (0)
LDL Cholesterol Targets after Ischemic Stroke. Reply. (2020) (0)
Are We All Hypo-Statinaemics? (2009) (0)
Baseline characteristics and One-year outcome in 4789 patients included in the TIA registry.org (2014) (0)
[Paresthesia of the fifth cranial nerve and homolateral carotid dissection]. (1987) (0)
Aortic and Common Carotid Artery Dissections (2005) (0)
[Rare cause of curable urinary incontinence: giant cell arteritis]. (1987) (0)
Abstract WP201: Sub-analysis of Japanese Versus Non-japanese on Background Characteristics and One-year Outcomes in Tiaregistry.org (2017) (0)
Clinical determinants of incident aortic valve stenosis in patients treated with atorvastatin: results from three large randomized clinical trials (2013) (0)
Cervical Pain and Headache as the Only Mandtestation of Extracranial Internal Carotid Artery Dissection (1991) (0)
[Management of cerebral ischemia in acute phase]. (2002) (0)
P109 FUNCTIONAL ANALYSES OF THE HUMAN LEUKOTRIENE C4 SYNTHASE GENE PROMOTER MOLECULAR HAPLOTYPES (2010) (0)
[Lateral inferior pontine infarction: 2 clinical aspects]. (1990) (0)
Lipid and Stroke (2005) (0)
Étude DIAS-2 (2009) (0)
Front & Back Matter (2014) (0)
Osteopontin Predicts Three-Month Outcome in Stroke Patients Treated by Reperfusion Therapies (2020) (0)
Statins, lipid lowering and stroke (2009) (0)
Abstract TP21: Impact Of Complete Recanalization On The Relationships Between Pretreatment Dwi Volume And Clinical Outcome In Patients Treated By Endovascular Treatment. (2013) (0)
The asymptomaticmyocardial Ischemia in stroke and atherosclerotic disease (A.M.I.ST.A.D.) study: Prevalence of coronary atherosclerosis in patients with cerebral infarction (2010) (0)
ÉTUDE ACTIVE-A (2009) (0)
Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial (2020) (0)
[Acute asphyxia caused by Gerhardt's syndrome in rheumatic pelvispondylitis]. (1986) (0)
University of Birmingham XANTUS : rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (2014) (0)
A of the Evidence for the Use of Telemedicine Within Stroke Systems of (2009) (0)
2013 ACC/AHA GUIDELINE RECOMMENDATION ON BLOOD CHOLESTEROL REVISITED: PERCENT LDL-C REDUCTION OR ATTAINED LDL-C LEVEL OR BOTH FOR PROGNOSIS? (2015) (0)
Iconographies supplémentaires de l'article : Accidents ischémiques cérébraux et chimiothérapie anti-cancéreuse (2008) (0)
Posterior Circulation Disorders (2009) (0)
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide (2022) (0)
[Management of acute phase cerebral ischemia]. (2003) (0)
Paresthésies du V et dissection carotidienne homolatérale (1987) (0)
Causal role of non-stenotic hypodense plaques with high FDG uptake detected with PET-CT angiography in patients with unknown cause of stroke? (2016) (0)
Introduction (2003) (0)
Abstract 15330: Work Productivity Losses in the Year Following Acute Coronary Syndrome or Stroke: Interim Results of a Multi-Country Survey in Europe (2017) (0)
NON-INTERVENTIONAL STUDY ON THE SAFETY OF RIVAROXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION IN ROUTINE CLINICAL PRACTICE: XANTUS (2015) (0)
[Is there a recrudescence of neurosyphilis? 7 cases observed in a 1-year period in non-carriers of the human immunodeficiency virus]. (1988) (0)
MS153 MOLECULAR INVESTIGATION OF THE FUNCTIONAL RELEVANCE OF MISSENSE VARIANTS OF ICAM-1 (2010) (0)
Abstract 5624: C-Reactive Protein Predicts First Coronary Events but Not Recurrent Stroke: Results From the SPARCL Study (2009) (0)
Does ABCD Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack? (2009) (0)
Short Communications Transesophageal Echocardiographic Detection of Aortic Arch Disease in Patients With Cerebral Infarction (2005) (0)
Reply (1995) (0)
SHORT Vermal infarct with pursuit eye movement disorders (0)
Response to Letter by Calvet et al Regarding Article, “Prevalence of Coronary Atherosclerosis in Patients With Cerebral Infarction” (2011) (0)
Trial or Transient Ischemic Attack : The Stroke Prevention by Aggressive Reduction in Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke (2007) (0)
Vascular neurology : passage to the therapeutic era (1999) (0)
[Magnetic resonance imaging and trimodal evoked potentials. Comparison of their respective value in the diagnosis of possible forms of multiple sclerosis]. (1987) (0)
Cryptogenic stroke and PFO diagnosis (2007) (0)
Abstract TMP16: Efficacy and Safety of Ticagrelor in Relation to Time to Loading Dose in the SOCRATES Trial (2017) (0)
A simple semi-quantitative score based on FDG-PET and CT angiography can help for the evaluation of stenotic carotid atherosclerotic plaques in symptomatic and asymptomatic patients. (2016) (0)
Stroke and plaque in the aortic arch (1997) (0)
Remote Ischemic Perconditioning for the Treatment of Acute Ischemic Stroke-Reply. (2020) (0)
Advances in Atrial Fibrillation-related Stroke Prevention (2015) (0)
Étude ThermoCool-AF (2010) (0)
Indications de l’occlusion de l’auricule gauche comme substitut à l’anticoagulation chez les patients qui ont un AVC lié à une fibrillation atriale : le registre WATCH-AF (2021) (0)
Quel bilan intracrânien ou aortique chez un patient ayant une sténose carotide (2007) (0)
CO-05 - IRM haute rsolution des artres sylviennes: rsultats prliminaires (2006) (0)
Apport de l’échographie des troncs supra-aortiques avec contraste en neurologie vasculaire : étude de 3 cas (2022) (0)
Neuropathie vésicale au cours du lupus érythémateux aigu disséminé (deux observations) (1988) (0)
A l’aube du traitement de l’infarctus cérébral : la thrombolyse (1996) (0)
Importance du cholestérol et de son traitement dans la prévention de l’AVC (2020) (0)
J - 26 Ophtalmoplégie douloureuse révélant une sarcoïdose (2007) (0)
Le risque primaire d'accident vasculaire cérébral (2008) (0)
Les dolichoectasies artérielles intracrâniennes (2002) (0)
Abstract 2365: Impact of Socioeconomic Level on Cardiovascular Risk in Ischemic Stroke Patients: The OPTIC Registry (2012) (0)
Reply to Ionita et al (2018) (0)
Troubles cognitifs aigus (2004) (0)
Artériopathie ectasiante intracrânienne : données récentes et conduite à tenir (2011) (0)
Lien entre le caractère hypodense et hypermétabolique de plaques non sténosantes sur la TEP-FDG couplée à l’angioscanner et la survenue d’AVC de cause inconnue ? (2016) (0)
Facteur VII recombinant : sera-t-il pour le traitement de l'hémorragie cérébrale ce que le rtPA est dans le traitement de l'ischémie cérébrale ? (2006) (0)
La chirurgie de l'artère carotide (2009) (0)
G - 17 Hémoglobinurie paroxystique nocturne et infarctus cérébral — Report d’un cas et revue de 10 cas de la littérature (2007) (0)
Statine et risque artériel cérébral (1998) (0)
Les infarctus du cervelet (1991) (0)
RISQUE D'ACCIDENT VASCULAIRE CEREBRAL ET TRAITEMENT HORMONAL SUBSTITUTIF (THS) POST-MENOPAUSIQUE (1998) (0)
FP08-MO-01 Rationale, design and patients' baseline characteristics of the PERFORM study (2009) (0)
Valeur pronostique du TBR aortique en TEP 18F-FDG concernant la survenue d’évènements athéro-thrombotiques chez des patients suivis pour maladie athéromateuse (2019) (0)
Mo-W4:2 Lipid and stroke (2006) (0)
Quel bilan coronaire chez un patient qui a une sténose carotide (2007) (0)
Athérome aortique et accident vasculaire cérébral ischémique (1995) (0)
Démence et leucoencéphalopathie régressives révélant une angiopathie amyloïde cérébrale (2001) (0)
Voir le cerveau souffrir (2000) (0)
La leucocephalopathie postérieure réversible medullaire (2019) (0)
Globe vésical à l'origine d'une méralgie paresthésique. (1987) (0)
Impact du traitement par HDL reconstitué avec l’ApoA1-Milano à la phase aiguë de l’infarctus cérébral : étude pré-clinique chez le rat (2017) (0)
Vascularite à varicelle-zona-virus (2019) (0)
Étude SPARCL : faut-il faire baisser fortement le cholestérol après une attaque cérébrale ? (2006) (0)
Reply (2020) (0)
Iconography : Artériopathie ectasiante intracrânienne : données récentes et conduite à tenir (2011) (0)
La sténose de l'artère carotide (2009) (0)
Reviewers for the Journal, 2006. (2007) (0)
Leucémie à tricholeucocytes, pronostic et infections opportunistes: une observation et revue de la littérature (1986) (0)
Asphyxie aiguë par syndrome de Gerhardt au cours d'une pelvispondylite rhumatismale (1986) (0)
Un train peut en cacher deux autres (2013) (0)
Paralysie bilatérale du nerf moteur oculaire externe à la suite d'une anesthésie péridurale : A propos d'un cas (1999) (0)
Y a-t-il une place pour la chirurgie dans le traitement des accidents ischémiques vertébro-basilaires en 1992? Le point de vue du neurologue (1992) (0)
Corrigendum to "HDL-C, triglycerides and carotid IMT: A meta-analysis of 21,000 patients with automated edge detection IMT measurement" [Atherosclerosis 232 (2014) 65-71]. (2018) (0)
Étude PROTECT-AF : l’occlusion percutanée de l’auricule gauche est-elle une alternative aux AVK ? (2009) (0)
[Multiple arterial dissections and inflammatory syndrome: apropos of 4 cases]. (1993) (0)
Intérêt diagnostique de l’analyse combinée TEP-FDG/angioscanner chez les patients avec plaques carotidiennes non sténosantes présentant un AVC de cause inconnue (2017) (0)
Actualités sur la neurologie vasculaire (2003) (0)
Risque à 3 mois, 1 an et 5 ans des accidents ischémiques transitoires et infarctus cérébraux mineurs dans une cohorte contemporaine, multicentrique, multinationale, multicontinentale de 4879 patients (2019) (0)
Aorticatherosclerosis: amarkerof cardiovascular risk (1997) (0)
Traitement endovasculaire pour le traitement des anévrysmes intracrâniens rompus (2006) (0)
G - 1 Troubles ventilatoires au cours du sommeil et infarctus lacunaires (2007) (0)
Une carotide pas commune (2023) (0)
Infarctus pontique paramédian révélant une neuroborréliose de Lyme : à propos d’un cas et revue de la littérature (2014) (0)
Neutralisation of IL12 p40 or IL23 p40 does not block infl ammation in multiple sclerosis (2008) (0)
Quand proposer une fermeture percutanée dans un foramen ovale perméable (2007) (0)
Étude ATHENA: Le traitement antiarythmique par dronédarone peut-il prévenir les AVC en association avec les AVK dans la fibrillation atriale ? (2010) (0)
Les dolichoectasies artérielles intracrâniennes dans l'étude cas-témoins GENIC: facteurs cliniques associés, type d'infarctus cérébral et pronostic à 5 ans (2003) (0)
G - 43 Thrombolyse intra-artérielle chez une femme enceinte (2007) (0)
Un nouveau pas vers la thrombolyse de l’infarctus cérébral (1998) (0)
Le concept de lacune est-il utile? (1992) (0)
Thrombolyse combinée intraveineuse et intra-artérielle à la phase aiguë de l’infarctus cérébral en cas d’occlusion artérielle (2009) (0)
Syndrome cérébelleux paranéoplasique d’un mélanome cutané : efficacité du traitement par anti-PD-1 (2017) (0)
Syndrome de Susac chez une femme enceinte, prise en charge diagnostique et thérapeutique (2016) (0)
Neurologie vasculaire : le passage à l’ère thérapeutique (1999) (0)
Sténoses carotides symptomatiques : intérêt de l’endartériectomie précoce chez les patients neurologiquement instables (2013) (0)
Infarctus cérébraux et thromboses carotidiennes après une infection à Mycoplasma pneumoniae (2007) (0)
Autoévaluations de l'article : Dolichoectasies artérielles intracrâniennes (2008) (0)
Ophtalmoplégia externe au cours d'une intoxication barbiturique. (1984) (0)
La sténose carotide expliquée au patient (2007) (0)
Étude GALA : anesthésie générale ou locale pour la chirurgie carotide ? (2009) (0)
Pneumonie et septicémie à Légionnella pneumophila: complication mortelle d'une leucémie à tricholeucocytes évoluant depuis 27 ans (1984) (0)
Exploration de l'aorte thoracique en échographie transœsophagienne pour le diagnostic des accidents vasculaires cérébraux (1995) (0)
Hémosidérose du névraxe post-chirurgicale traitée par défériprone (2016) (0)
Prévalence autopsique de l'athérosclérose intracrânienne et extracrânienne proximale chez les patients décédés d'un accident vasculaire cérébral (2008) (0)
La neurosyphilis est-elle en recrudescence? sept cas observés en 1 an chez des malades non porteurs du virus de l'immunodéficience humaine (1988) (0)
CO-07 IRM haute-résolution de la plaque du tronc basilaire au cours de l’infarctus pontique paramédian (2005) (0)
Des microbleeds, là où on ne les attendait pas (2013) (0)
Intérêt de développer des cliniques d’AIT en France : est-ce utile pour la santé publique ? (2018) (0)
L’inhibition de PCSK9 associée à une hypoLDLémie n’augmente pas le risque de transformation hémorragique après une ischémie/reperfusion cérébrale (2014) (0)
Intérêt de l'IRM dans un cas de miliaire carcinomateuse cérébro-méningée d'origine mélanique (1990) (0)
Statines en prévention des accidents vasculaires cérébraux et de l’athérosclérose carotidienne : méta-analyse (2005) (0)
Étude RE-LY (2009) (0)
Accident vasculaire cérébral et troubles de l’audition : à propos de 4 cas (2014) (0)
Exploration des plaques sténosantes carotidiennes symptomatiques et asymptomatiques : un score semi-quantitatif simple combinant la TEP-18FDG et l’angioscanner (2016) (0)
Troubles cognitifs aigus révélateurs d’un accident vasculaire cérébral (2006) (0)
Imagerie par résonance magnétique et potentiels évoqués trimodaux: comparaison de leur intérêt respectif dans le diagnostic des formes possibles de sclérose en plaques (1987) (0)
Vascular Pathology (2018) (0)
[Static tremor and encephalopathy disclosing Conn's syndrome]. (1989) (0)
Contents Vol. 18, 2004 (2004) (0)
CV4 - PATIENT AND CAREGIVER INDIRECT COSTS AFTER ACUTE CARDIOVASCULAR EVENTS IN EUROPE (2018) (0)
24th International conference on stroke and cerebral circulation de l’American Stroke Association, 4-6 février 1999 (1999) (0)
THE INTRACRANIAL-B2LEED3S SCORE AND THE RISK OF INTRACRANIAL HEMORRHAGE IN ISCHAEMIC STROKE PATIENTS UNDER ANTIPLATELET TREATMENT (low Body mass index, Blood pressure, Lacune, Elderly, asian Ethnicity, cardiovascular Disease, cerebrovascular Disease, Dual antithrombotic treatment or anticoagulant, S (2016) (0)
Abstract TP438: Japanese versus Non-Japanese Patients With Transient Ischemic Attack or Minor Stroke: Five-Year Risk of Stroke and Vascular Events (2020) (0)
Intracranial dolichoarterial dilatation (2002) (0)
24th International conference on stroke and cerebral circulation de l’American Stroke Association (February 4-6 1999) (1999) (0)
Abstract MP4: Ticagrelor Plus Aspirin Versus Aspirin Alone in Acute Ischemic Stroke or TIA - Analysis of Bleeding Events in the THALES Trial (2021) (0)
International TIA/ACVS Conference: International Conference, Tokyo, November 2013: Abstracts (2013) (0)
Practice Guidelines (8th Edition) Chest Physicians Evidence-Based Clinical for Ischemic Stroke: American College of Antithrombotic and Thrombolytic Therapy (2008) (0)
Reviewers January 2008—November 2008 (2009) (0)
Front & Back Matter (2015) (0)
Abstract TMP119: The Second Report of Japanese Sub-Analysis of TIAregistry.org (2018) (0)
Cardiovascular Risk Factor Management in the Prevention of Stroke: Satellite Symposium Held on the Occasion of the 11th European Stroke Conference, Geneva, May 2002: Proceedings (2003) (0)
The PRoFESS study (2009) (0)
Iconographies supplémentaires de l'article : Dolichoectasies artérielles intracrâniennes (2008) (0)
[Disorders of equilibrium caused by an infratentorial lipoma. Apropos of 2 cases studied with MRI]. (1988) (0)
Dissections artérielles multiples et syndrome inflammatoire: à propos de 4 observations (1993) (0)
International Collaborations Are Essential for Stroke. (2019) (0)
Carotid Endarterectomy in the Acute Phase of Stroke-in-evolution: An Update (2019) (0)
Impact of Lower Versus Higher LDL Cholesterol Targets on Cardiovascular Events After Ischemic Stroke in Patients With Diabetes (2021) (0)
Abstract 12937: The Risk for Major Bleeding Was Similar in Patients Receiving Ticagrelor or Aspirin After TIA or Acute Ischemic Stroke in the SOCRATES Study (2016) (0)
ATORVASTATIN REDUCES TOTAL EVENTS OVERALL AND ACROSS VASCULAR BEDS IN THE SPARCL TRIAL (2020) (0)
Coronary artery disease Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure (2014) (0)
Early Carotid Endarterectomy after Thrombolysis for Acute Ischemic Stroke (2014) (0)
Abstract 15761: Outcomes After Ablation And Cardioversion in Patients With Non-valvular Atrial Fibrillation: Results From the XANTUS Study (2016) (0)
Subject Index Vol. 31, 2011 (2011) (0)
Acknowledgement to referees (2008) (0)
Front & Back Matter (2013) (0)
A Role of Platelet Activation in Lacunar Stroke (2012) (0)
[Incidental finding of an isolated thrombus in the left atrium in a young woman with sinus rhythm 5 years after cerebral ischemic accident]. (1993) (0)
Prevention and health services delivery. (2005) (0)
Potential Yield of Diffusion-Weighted Imaging in Lacunar Stroke Syndromes (2000) (0)
Accident ischémique cérébral et rétinien transitoire (2005) (0)
MONOCYTE CHEMOATTRACTANT PROTEIN 1 PREDICTS FIRST CORONARY EVENTS BUT NOT RECURRENT STROKES: RESULTS FROM THE SPARCL STUDY (2010) (0)
Dolicoectasie arteriose intracraniche (2008) (0)
ES7 DIRECT MEDICAL COSTS OF STROKE ACCORDING TO HANDICAP LEVELS AFTER 12 AND 18 MONTHS (2006) (0)
Lipid Lowering and Recurrent Stroke: A Definitive Answer? (2007) (0)
3WS17-3 Statins in stroke prevention: After ALLHAT and PROSPER, disappointment or reasons to hope? (2003) (0)
0171: Identification of complicated carotid plaques by adding functional fluorodeoxyglucose-positron emission tomographic imaging to morphological characteristics on computed tomographic angiography (2016) (0)
Thrombolyse intra-artérielle et infarctus cérébral (2002) (0)
Randomised trials of endovascular treatment of stroke are needed – Authors' reply (2010) (0)
The cause of cerebral infarction: prevalence of ulcerated plaques in the aortic arch (1993) (0)
The importance of EXPRESS treatment for transient ischemic attack (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Pierre Amarenco?

Pierre Amarenco is affiliated with the following schools:

Pierre Amarenco's Academic­Influence.com Rankings

Pierre Amarenco's Degrees

Why Is Pierre Amarenco Influential?

Pierre Amarenco's Published Works

Published Works

What Schools Are Affiliated With Pierre Amarenco?

Pierre Amarenco's AcademicInfluence.com Rankings